Industries > Pharma > Medical Device Leader Series: Top Pre-Filled Injection Device Manufacturers 2018-2028

Medical Device Leader Series: Top Pre-Filled Injection Device Manufacturers 2018-2028

Profiles, R&D and Revenue Forecasting for Leading Syringe, Injector and Component Producers and Contract Filling Services

PUBLISHED: 13 November 2018
PAGES: 213
PRODUCT CODE: PHA0340
SUBMARKET: Medical Devices

WOOCS 2.2.1
DOWNLOAD FREE SAMPLE
SKU: PHA0340 Categories: , Tags: , , , , ,

The Pre-Filled Device Manufacturing market is estimated to reach $7.5bn in 2022, growing at a CAGR of 10.5% from 2017 to 2022.

The majority of revenues for pre-filled syringe manufacturers, including component manufacturers and pen injector/autoinjector manufacturers, came from developed markets. In 2017, the US was the largest market for pre-filled injection devices, accounting for 39.9% of global revenues.

How this 213-page report delivers:

• Provides an overview and revenue forecasts of the global pre-filled injectable devices market from 2018 to 2028

• Profiles of selected leading companies in the pre-filled injection device manufacturing:
• Leading pre-filled syringe manufacturers
• Leading pre-filled injectable component manufacturers
• Leading pen injector and autoinjector manufacturers
• Leading pre-filled injectable devices contract manufacturers

• Companies profiled in this report:
• Aptar Stelmi
• Becton, Dickinson, & Co (BD)
• Bespak Injectables
• Boehringer Ingelheim
• Catalent
• Dätwyler Holding
• Gerresheimer
• Haselmeier
• Laboratorios Farmacéuticos ROVI
• Nemera
• Nipro
• Ompi
• Owen Mumford
• Roselabs Group.
• Schott
• SHL Group
• Tip-top
• Vetter Pharma
• Weigao Group Pharmaceutical Packaging Products Company
• West Pharmaceutical Services.
• Ypsomed

Top Pre-Filled Injection Device Manufacturers 2018-2028

• Information provided for the selected leading companies, when available:
• Overview of the company
• Historical Revenues
• Revenue forecasts from 2018-2028
• A SWOT analysis
• A competitive analysis
• Products & Services
• Business Developments: Expansion, new products, mergers, acquisitions, collaborations.

• This report also discusses the key trends in the pre-filled injection device manufacturing market.

101 charts unavailable elsewhere

Visiongain’s study is intended for anyone requiring commercial analyses for the pre-filled injection device manufacturing market. You find data, trends and predictions.

Buy our report today Top Pre-Filled Injection Device Manufacturers 2018-2028: Profiles, R&D and Revenue Forecasting for Leading Syringe, Injector and Component Producers and Contract Filling Services.

Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6

Download sample pages

Complete the form below to download your free sample pages for Medical Device Leader Series: Top Pre-Filled Injection Device Manufacturers 2018-2028


Download sample pages

Complete the form below to download your free sample pages for Medical Device Leader Series: Top Pre-Filled Injection Device Manufacturers 2018-2028


Latest Pharma news

Visiongain Publishes Pharma Wholesale and Distribution Market Report 2022-2032

The pharma wholesale and distribution market was valued at US$511.80 billion in 2021 and is projected to grow at a CAGR of 7.84% during the forecast period 2022-2032.

29 September 2022

READ

Visiongain Publishes Mesenchymal Stem Cells Market Report 2022-2032

The mesenchymal stem cells market was valued at US$2.44 billion in 2021 and is projected to grow at a CAGR of 13.82% during the forecast period 2022-2032.

21 September 2022

READ

Visiongain Publishes Advanced Wound Care Management Market Report 2022-2032

The global advanced wound care management market is estimated to be valued at US$12,581.3 million in 2022. The market is projected to reach a market value of US$23,307.5 million by 2032 and is projected to grow at a CAGR of 6.36% during the forecast period 2022-2032.

16 September 2022

READ

Visiongain Publishes Gene Therapy R&D Market Report 2022-2032

The gene therapy R&D market was valued at US$1,653.0 million in 2021 and is projected to grow at a CAGR of 30.1% during the forecast period 2022-2032.

15 September 2022

READ